Page last updated: 2024-08-21

myristic acid and imatinib mesylate

myristic acid has been researched along with imatinib mesylate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cowan-Jacob, SW; Fabbro, D; Fendrich, G; Jahnke, W; Liebetanz, J; Manley, PW; Meyer, T1
Fujita, A; Inamoto, E; Narumiya, S; Shishido, T; Watanabe, N; Yuan, Y1
Adrian, F; Berst, F; Cowan-Jacob, SW; Fabbro, D; Fendrich, G; Furet, P; Gray, NS; Grotzfeld, R; Jahnke, W; Liebetanz, J; Manley, PW; Marzinzik, A; Mestan, J; Pelle, X; Strauss, A; Szyttenholm, A; Warmuth, M; Zhang, J1
Chen, S; Engen, JR; Iacob, RE; Panjarian, S; Smithgall, TE1

Reviews

1 review(s) available for myristic acid and imatinib mesylate

ArticleYear
Structure and dynamic regulation of Abl kinases.
    The Journal of biological chemistry, 2013, Feb-22, Volume: 288, Issue:8

    Topics: Benzamides; Fusion Proteins, bcr-abl; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; Models, Chemical; Molecular Conformation; Mutation; Myristic Acid; Piperazines; Protein Binding; Protein Structure, Tertiary; Proto-Oncogene Mas; Pyrimidines; src Homology Domains

2013

Other Studies

3 other study(ies) available for myristic acid and imatinib mesylate

ArticleYear
The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
    Structure (London, England : 1993), 2005, Volume: 13, Issue:6

    Topics: Amino Acid Sequence; Benzamides; Binding Sites; Conserved Sequence; Crystallography, X-Ray; Enzyme Activation; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Imatinib Mesylate; Inhibitory Concentration 50; Leucine; Models, Chemical; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Myristic Acid; Nuclear Magnetic Resonance, Biomolecular; Phosphorylation; Piperazines; Protein Binding; Proto-Oncogene Proteins c-abl; Pyrimidines; Sequence Homology, Amino Acid; src Homology Domains; src-Family Kinases; Tyrosine

2005
Imatinib mesylate (STI571)-induced cell edge translocation of kinase-active and kinase-defective Abelson kinase: requirements of myristoylation and src homology 3 domain.
    Molecular pharmacology, 2009, Volume: 75, Issue:1

    Topics: Animals; Benzamides; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Fibroblasts; Fluorescent Dyes; Fusion Proteins, bcr-abl; Green Fluorescent Proteins; Imatinib Mesylate; Mice; Myristic Acid; Phosphotransferases; Piperazines; Point Mutation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Pyrimidines; src Homology Domains; Transfection; Xenopus laevis

2009
Inhibitors of the Abl kinase directed at either the ATP- or myristate-binding site.
    Biochimica et biophysica acta, 2010, Volume: 1804, Issue:3

    Topics: Adenosine Triphosphate; Allosteric Regulation; Benzamides; Crystallography, X-Ray; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Mutation, Missense; Myristic Acid; Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Piperazines; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-abl; Pyrimidines

2010